If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
630.00    0.00 (0.00%)
Bid:
620.00
Ask:
640.00
Spread: 20.00 (3.226%)
Market Cap: £211.82m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Sigma signs £25m Long Term Agreement

13 Feb 2013 10:00

AVINGTRANS PLC - Sigma signs £25m Long Term Agreement

AVINGTRANS PLC - Sigma signs £25m Long Term Agreement

PR Newswire

London, February 13

13 February 2013

Avingtrans Plc ("Avingtrans" or the "Company" or the "Group") Sigma signs £25m Long Term Agreement ("LTA") with Safran Aircelle

Avingtrans (AIM:AVG), a manufacturer of critical components and associatedservices to the global aerospace, energy and medical sectors is pleased toannounce that Sigma Components - Farnborough Ltd, part of Avingtrans plc'sAerospace Division, has signed a long term agreement (LTA) with SafranAircelle.

Safran Aircelle is an existing client of the PFW Farnborough business thatAvingtrans acquired in December 2012. The contract, which is valued at circa £25 million of revenue to Avingtrans over its duration of 10 years, includes theexisting scope of the commercial agreement between the two companies and is tosupply various fabricated assemblies.

Mark Johnson, Managing Director of the Aerospace Division, commented:

"We are very pleased to announce this LTA with Safran Aircelle which is aresult of the ongoing integration of the Farnborough business and whichcontinues the impressive momentum that we have been building in the AerospaceDivision. Along with the LTA that we signed with Rolls Royce in December oflast year, we are building a good visibility of long term revenue which is anexcellent base from which we can continue to grow the business."

Enquiries:Avingtrans plc 0115 949 9020Steve McQuillan, CEOStephen King, CFONumis

David Poutney (Corporate Broking) 0207 260 1000

Richard Thomas (Corporate Finance and Nominated Adviser)

Newgate Threadneedle 020 7653 9850(Financial PR)

Josh Royston / Heather Armstrong

About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered componentsand services to the Aerospace, Energy and Medical markets worldwide.

The business is made up of 2 divisions:• Aerospace, engaged in the manufacture of rigid pipe assemblies,

fabrications and prismatic components - both metallic and composite - for

the global aerospace market and precision polishing of aircraft components

and;

• Energy and medical, engaged in the manufacture of machined and fabricated

pressure and vacuum vessels and components for the energy, medical, science

and research communities. Plus, design and manufacture of fabricated poles

and cabinets for roadside safety cameras and rail track signalling.

Date   Source Headline
24th Jun 20267:00 amRNSTrading Update and Notice of Results
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.